TBPH Stock Summary and Trading Ideas (Theravance Biopharma - | NASDAQ:TBPH)

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

What symbol and exchange does Theravance Biopharma - shares trade?

Theravance Biopharma - trades on the NASDAQ stock market under the symbol TBPH.

What is Theravance Biopharma - stock price doing today?

As of July 31, 2026, TBPH stock price climbed to $16.86 with 340,646 million shares trading.

What is Theravance Biopharma -'s Beta?

TBPH has a beta of 0.95, meaning it tends to be less sensitive to market movements. TBPH has a correlation of 0.06 to the broad based SPY ETF.

How much is Theravance Biopharma - worth?

TBPH has a market cap of $873.82 million. This is considered a Small Cap stock.

How much money does Theravance Biopharma - make?

Last quarter Theravance Biopharma - reported $18 million in Revenue and -$.10 earnings per share. This beat revenue expectation by $151,000 and missed earnings estimates by -$.16.

What is the highest and lowest price Theravance Biopharma - traded in the last 3 year period?

In the last 3 years, TBPH traded as high as $21.03 and as low as $7.44.

What are the top ETFs holding Theravance Biopharma -?

The top ETF exchange traded funds that TBPH belongs to (by Net Assets): VTI, IWM, VXF, IBB, IWO.

Is Theravance Biopharma - (TBPH) a good investment?

TBPH has outperformed the market in the last year with a return of +51.1%, while the SPY ETF gained +19.4%. However, in the most recent history, TBPH shares have underperformed the stock market with its stock returning +0.7% in the last 3 month period and -0.4% for the last 2 week period, while SPY has returned +4.2% and +0.5%, respectively.

What are the support and resistance levels for Theravance Biopharma - (TBPH)?

TBPH support price is $16.76 and resistance is $16.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TBPH shares will trade within this expected range on the day.